Works matching IS 15747891 AND DT 2016 AND VI 10 AND IP 1

Results: 15

Interleukin-33 predicts poor prognosis and promotes ovarian cancer cell growth and metastasis through regulating ERK and JNK signaling pathways.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 113, doi. 10.1016/j.molonc.2015.06.004

By:

Tong, Xiaoguang;
Barbour, Mark;
Hou, Kezuo;
Gao, Chao;
Cao, Shuang;
Zheng, Jingli;
Zhao, Yang;
Mu, Rong;
Jiang, Hui-Rong

Publication type:

Article

p53-Based strategy to reduce hematological toxicity of chemotherapy: A proof of principle study.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 148, doi. 10.1016/j.molonc.2015.09.004

By:

Ha, Chul S.;
Michalek, Joel E.;
Elledge, Richard;
Kelly, Kevin R.;
Ganapathy, Suthakar;
Su, Hang;
Jenkins, Carol A.;
Argiris, Athanassios;
Swords, Ronan;
Eng, Tony Y.;
Karnad, Anand;
Crownover, Richard L.;
Swanson, Gregory P.;
Goros, Martin;
Pollock, Brad H.;
Yuan, Zhi-Min

Publication type:

Article

Sensitivity of plasma BRAFmutant and NRASmutant cell-free DNA assays to detect metastatic melanoma in patients with low RECIST scores and non-RECIST disease progression.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 157, doi. 10.1016/j.molonc.2015.09.005

By:

Chang, Gregory A.;
Tadepalli, Jyothirmayee S.;
Shao, Yongzhao;
Zhang, Yilong;
Weiss, Sarah;
Robinson, Eric;
Spittle, Cindy;
Furtado, Manohar;
Shelton, Dawne N.;
Karlin-Neumann, George;
Pavlick, Anna;
Osman, Iman;
Polsky, David

Publication type:

Article

Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 40, doi. 10.1016/j.molonc.2015.08.001

By:

Koczorowska, M.M.;
Tholen, S.;
Bucher, F.;
Lutz, L.;
Kizhakkedathu, J.N.;
De Wever, O.;
Wellner, U.F.;
Biniossek, M.L.;
Stahl, A.;
Lassmann, S.;
Schilling, O.

Publication type:

Article

Determination of cell uptake pathways for tumor inhibitor lysyl oxidase propeptide.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 1, doi. 10.1016/j.molonc.2015.07.005

By:

Ozdener, Gokhan Baris;
Bais, Manish V.;
Trackman, Philip C.

Publication type:

Article

Genomic signatures for paclitaxel and gemcitabine resistance in breast cancer derived by machine learning.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 85, doi. 10.1016/j.molonc.2015.07.006

By:

Dorman, Stephanie N.;
Baranova, Katherina;
Knoll, Joan H.M.;
Urquhart, Brad L.;
Mariani, Gabriella;
Carcangiu, Maria Luisa;
Rogan, Peter K.

Publication type:

Article

Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 73, doi. 10.1016/j.molonc.2015.08.003

By:

Baenke, Franziska;
Chaneton, Barbara;
Smith, Matthew;
Van Den Broek, Niels;
Hogan, Kate;
Tang, Haoran;
Viros, Amaya;
Martin, Matthew;
Galbraith, Laura;
Girotti, Maria R.;
Dhomen, Nathalie;
Gottlieb, Eyal;
Marais, Richard

Publication type:

Article

mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 101, doi. 10.1016/j.molonc.2015.08.004

By:

Massey, Andrew J.;
Stephens, Peter;
Rawlinson, Rebecca;
McGurk, Lauren;
Plummer, Ruth;
Curtin, Nicola J.

Publication type:

Article

Personalised pathway analysis reveals association between DNA repair pathway dysregulation and chromosomal instability in sporadic breast cancer.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 179, doi. 10.1016/j.molonc.2015.09.007

By:

Liu, Chao;
Srihari, Sriganesh;
Lal, Samir;
Gautier, Benoît;
Simpson, Peter T.;
Khanna, Kum Kum;
Ragan, Mark A.;
Lê Cao, Kim-Anh

Publication type:

Article

Altered purinergic receptor-Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 166, doi. 10.1016/j.molonc.2015.09.006

By:

Azimi, Iman;
Beilby, Hannah;
Davis, Felicity M.;
Marcial, Daneth L.;
Kenny, Paraic A.;
Thompson, Erik W.;
Roberts-Thomson, Sarah J.;
Monteith, Gregory R.

Publication type:

Article

Transcriptional profiling of dividing tumor cells detects intratumor heterogeneity linked to cell proliferation in a brain tumor model.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 126, doi. 10.1016/j.molonc.2015.09.001

By:

Endaya, Berwini B.;
Lam, Paula Y.P.;
Meedeniya, Adrian C.B.;
Neuzil, Jiri

Publication type:

Article

Editorial Board.

Published in:: Molecular Oncology, 2016, v. 10, n. 1, p. ii, doi. 10.1016/S1574-7891(15)00231-8
Publication type:: Article

4-protein signature predicting tamoxifen treatment outcome in recurrent breast cancer.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 24, doi. 10.1016/j.molonc.2015.07.004

By:

De Marchi, Tommaso;
Liu, Ning Qing;
Stingl, Cristoph;
Timmermans, Mieke A.;
Smid, Marcel;
Look, Maxime P.;
Tjoa, Mila;
Braakman, Rene B.H.;
Opdam, Mark;
Linn, Sabine C.;
Sweep, Fred C.G.J.;
Span, Paul N.;
Kliffen, Mike;
Luider, Theo M.;
Foekens, John A.;
Martens, John W.M.;
Umar, Arzu

Publication type:

Article

Serum N-glycan analysis in breast cancer patients – Relation to tumour biology and clinical outcome.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 59, doi. 10.1016/j.molonc.2015.08.002

By:

Haakensen, Vilde D.;
Steinfeld, Israel;
Saldova, Radka;
Shehni, Akram Asadi;
Kifer, Ilona;
Naume, Bjørn;
Rudd, Pauline M.;
Børresen-Dale, Anne-Lise;
Yakhini, Zohar

Publication type:

Article

High HER2 protein levels correlate with increased survival in breast cancer patients treated with anti-HER2 therapy.

Published in:

Molecular Oncology, 2016, v. 10, n. 1, p. 138, doi. 10.1016/j.molonc.2015.09.002

By:

Nuciforo, Paolo;
Thyparambil, Sheeno;
Aura, Claudia;
Garrido-Castro, Ana;
Vilaro, Marta;
Peg, Vicente;
Jimenez, José;
Vicario, Rocio;
Cecchi, Fabiola;
Hoos, William;
Burrows, Jon;
Hembrough, Todd;
Ferreres, Juan Carles;
Perez-Garcia, José;
Arribas, Joaquin;
Cortes, Javier;
Scaltriti, Maurizio

Publication type:

Article